First Heartland Consultants’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-1,320
| Closed | -$34 | – | 456 |
|
|
2024
Q2 | $34 | Sell |
1,320
-9,216
| -87% | -$237 | ﹤0.01% | 443 |
|
|
2024
Q1 | $714K | Buy |
10,536
+4,179
| +66% | +$283K | 0.07% | 204 |
|
|
2023
Q4 | $428K | Buy |
6,357
+71
| +1% | +$4.78K | 0.05% | 231 |
|
|
2023
Q3 | $426K | Buy |
+6,286
| New | +$426K | 0.05% | 235 |
|
|
2022
Q1 | – | Sell |
-5,330
| Closed | -$310 | – | 352 |
|
|
2021
Q4 | $310 | Sell |
5,330
-285
| -5% | -$17 | 0.01% | 266 |
|
|
2021
Q3 | $337K | Buy |
+5,615
| New | +$337K | 0.05% | 256 |
|